Editas Medicine Inc. (EDIT)
NASDAQ: EDIT
· Real-Time Price · USD
2.25
0.15 (7.14%)
At close: Jun 24, 2025, 3:59 PM
2.26
0.22%
Pre-market: Jun 25, 2025, 06:00 AM EDT
7.14% (1D)
| Bid | 2.25 |
| Market Cap | 188.77M |
| Revenue (ttm) | 31.18M |
| Net Income (ttm) | -251.23M |
| EPS (ttm) | -3.04 |
| PE Ratio (ttm) | -0.74 |
| Forward PE | -1.95 |
| Analyst | Hold |
| Ask | 2.26 |
| Volume | 2,826,341 |
| Avg. Volume (20D) | 2,082,291 |
| Open | 2.15 |
| Previous Close | 2.10 |
| Day's Range | 2.15 - 2.31 |
| 52-Week Range | 0.91 - 6.05 |
| Beta | 2.10 |
About EDIT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EDIT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EDIT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Editas Medicine Inc. is scheduled to release its earnings on Aug 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
-23.81%
Editas Medicine shares are trading lower after Sti...
Unlock content with
Pro Subscription
6 months ago
-5.03%
Editas Medicine shares are trading higher after the company announced plans to transition to an in vivo focus and initiated a reduction in headcount, aiming to eliminate approximately 65% of its workforce over the next six months.
